Quality Evaluation of Clinical Guidelines for Acute Myocardial Infarction Based on AGREE Ⅱ
10.13422/j.cnki.syfjx.20250896
- VernacularTitle:基于AGREEⅡ对急性心肌梗死临床指南的质量评价
- Author:
Shuyu GUAN
1
;
Tianying CHANG
2
;
Jiankang WANG
1
;
Hang SHANG
1
;
Yueying ZHANG
3
;
Jiajuan GUO
2
;
Yingzi CUI
2
Author Information
1. Changchun University of Traditional Chinese Medicine，Changchun 130117，China
2. Affiliated Hospital of Changchun University of Chinese Medicine，Changchun 130021，China
3. China Academy of Chinese Medical Sciences，Beijing 100700，China
- Publication Type:Journal Article
- Keywords:
acute myocardial infarction;
clinical guidelines;
expert consensus;
appraisal of guidelines for research and evaluation Ⅱ（AGREE Ⅱ）;
quality evaluation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2025;31(10):201-209
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveThis paper used the AGREE Ⅱ guideline evaluation tool to evaluate the quality of 14 clinical guidelines for acute myocardial infarction，aiming to provide reference for the formulation and improvement of the guidelines. MethodsClinical guidelines and expert consensus related to acute myocardial infarction were searched by web search. The search period ranges from January 1，2019 to November 1，2024 in CNKI，VIP，Wanfang Data，SinoMed，Web of Science，OVID， the International Guidelines Collaboration Network （GIN），the UK National Institute for Health and Clinical Excellence （NICE），Yimaitong， and other platforms. Three researchers independently screened the literature and used AGREE Ⅱ to score the screening results. After ensuring that the researchers have a consistent understanding of each guideline，the quality of the guidelines was evaluated. After that，the ratings were analyzed by layer according to the issuing agency，category，method of formulation，and funding situation and compared longitudinally by rating time. The clinical guidelines and expert consensus were compared in terms of content and evidence. ResultsA total of 14 guidelines and consensus were included. The results of AGREE Ⅱ in the six areas in descending order were scope and purpose （62.82%±10.43%），rigor （62.40%±12.77%），editorial independence （62.11%±22.26%），participants （61.42%±11.65%），clarity of expression （59.98%±9.62%），and application （52.94%±16.90%） . Eleven of the guidelines were at level B， and three were at level A. In the stratified analysis，the score of the guideline formulated by the Chinese Medical Doctor Association was lower. There was little difference between the scores of Chinese/Western and Western medicine guidelines. The average score of the guidelines was higher than the consensus. Funded guidelines and consensus scores were higher. In the longitudinal comparison，the highest number of guidelines were developed in 2020 and 2021，while those developed in 2023 scored the highest. In the differential comparison analysis，the content of the guidelines was more comprehensive， and the evidence level was higher，while the content of the consensus was more novel， and the evidence was less. ConclusionThe AGREE Ⅱ score of the clinical guidelines for acute myocardial infarction is generally moderate，and there is room for improvement in terms of applicability. At the same time，the content quality of expert consensus should be improved，and more efforts should be made to develop and apply Chinese medicine guidelines for complications such as heart failure and microcirculatory obstruction after acute myocardial infarction.
